ASH News Daily 2012 - Saturday, December 8, 2012 - (Page B-1)

ASH NewS DAily ® 54th Annual Meeting of the American Society of Hematology Read this issue online at www.hematology.org/ashnewsdaily2012_saturday Schedule 7:00 a.m. – 6:00 p.m. Registration GWCC ASH Central (International Blvd. Concourse between Buildings A & B) 7:30 – 9:00 a.m. Education/Scientific Program 9:00 a.m. – 7:30 p.m. Poster Session I – Viewing GWCC Hall B1-B2 9:30 – 11:00 a.m. Education/Scientific Program 11:00 a.m. – 5:00 p.m. Exhibit Hall Open GWCC Hall B3-B4 11:15 a.m. – 12:15 p.m. Career-Development Lunch Sessions Open to trainees wearing a blue badge only 12:00 noon – 1:30 p.m. Simultaneous Oral Sessions 2:00 – 3:30 p.m. Education/Scientific Program 4:00 – 5:30 p.m. Education/Scientific Program 5:30 – 7:30 p.m. Poster Session I – Presentations GWCC Hall B1-B2 Reception Honors 2012 MMSAP Participants and 2013 ASH-AMFDP Award Winner NHLBI Director to Speak T nounced. Dr. Garrett-Bakelman is an instructor of medicine at Weill his evening from 6:30 to 9:30 Cornell Medical College in New p.m., ASH will host the annual York, where her research focuses on Promoting Minorimyeloid malignanties in Hematology Presencies in the laboratory tations and Reception at the of Ari Melnick, MD. Omni Hotel at CNN CenDr. Garrett-Bakelman ter in the Grand Ballroom also serves as an asABCD. The event will ofsistant attending fer attendees opportuniphysician at New ties to network with colYork Presbyterian leagues, medical students, Hospital where she and ASH leadership, while is part of the Leukelearning about the details mia Program. Having of the Society’s Minority received her underMedical Student Award graduate bachelor of Program (MMSAP) and Francine Garrettscience degree from the ASH-Harold Amos Bakelman, MD, PhD California State UniFaculty Development Proversity, Fullerton, her gram (AMFDP). senior research activAt the reception, 2012 MMSAP ities were supported by an American participants will present their Chemical Society Academic Scholsummer research projects. During arship. She went on to receive her the presentations, the 2013 ASH- medical degree from the Albert EinAMFDP recipient, Francine Garrett- stein College of Medicine, Yeshiva Bakelman, MD, PhD, will be an- University, Bronx, NY, completing her graduate studies at Albert Einstein. Dr. Garrett-Bakelman’s PhD thesis focused on chromatin structure at the immunoglobulin heavychain locus. Her graduate work was supported by an NCI Individual National Pre-Doctoral Research Service Award, a UNCF-MERCK Graduate Science research Dissertation Fellowship, and a National Medical Fellowships Academic Medicine Fellowship for minority students. »» RECEPTION Page B-11 Don’t miss today’s Grassroots Network Lunch from 11:15 a.m. to 12:15 p.m. in International Ballroom D, Omni Hotel at CNN Center. The ASH Foundation Editor’s Note: This two-part article was originally published The Hematologist. The chair and vicechair of the ASH Development Committee were interviewed and discussed why the ASH Foundation is being established and what it will accomplish. IN THIS SECTION ASH Practice Forum and Reception B-5 Physician-Scientist Career-Development Award B-12 Minority Medical Student Award Recipients B-14 Dining in Atlanta B-24 A SH has set aside $9 million to support the start of the ASH Bridge Grant Program through the ASH Foundation, which launched in early November and is dedicated to Moving Hematology Forward. The Foundation will first focus on providing support for critical research needs and will expand to develop programs that inspire the next generation of hematologists and that advance the quality of care for patients with hematologic disorders. James George, MD, of the University of Oklahoma Health Sciences Center in Oklahoma City, is chair of the Development Committee. He is past president of ASH and the recipient of the 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology. Jay Bradner, MD, of the Dana-Farber Cancer Institute and Harvard Medical School in Boston, is vice-chair of the Development Committee. He is a physicianscientist with an interest in both benign and malignant hematologic diseases working at the interface of cell biology and chemistry. Dr. Bradner leads an academic research group focused on identify- ing and developing targeted agents and moving them from the discovery phase to the clinic. Q: Why does ASH need a foundation? Dr. George: I am concerned about the future of hematology research and the care of patients with hematologic disorders. Federal support for research through the National Institutes of Health has decreased every year for the past nine years. The uncertain future of academic careers in hematology is seriously limiting our ability to recruit the next generation of trainees. I’m alarmed by the possibility that »» ASH FOUNDATION Page B-8  http://www.hematology.org/ashnewsdaily2012_saturday

Table of Contents for the Digital Edition of ASH News Daily 2012 - Saturday, December 8, 2012

ASH News Daily 2012 - Saturday, December 8, 2012

https://www.nxtbookmedia.com